rDEN3Δ30
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rDEN3Δ30, covering 2016-11-30 to 2016-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine [Phase 1]